CLOZAPINE ANTAGONISM OF D-1 AND D-2 DOPAMINE RECEPTOR-MEDIATED BEHAVIORS

被引:51
作者
CRISWELL, HE
MUELLER, RA
BREESE, GA
机构
关键词
D O I
10.1016/0014-2999(89)90698-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:141 / 147
页数:7
相关论文
共 35 条
[1]  
Andersen P H, 1986, Adv Exp Med Biol, V204, P73
[3]   EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J].
ANDERSEN, PH ;
BRAESTRUP, C .
JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) :1822-1831
[4]   INHIBITION OF SKF38393-INDUCED AND PERGOLIDE-INDUCED CIRCLING IN RATS WITH UNILATERAL 6-OHDA LESION IS CORRELATED TO DOPAMINE D-1 AND D-2 RECEPTOR AFFINITIES INVITRO [J].
ARNT, J ;
HYTTEL, J .
JOURNAL OF NEURAL TRANSMISSION, 1986, 67 (3-4) :225-240
[5]   DOPAMINERGIC MECHANISMS AND MOTOR FUNCTION - CHARACTERIZATION OF D-1 AND D-2 DOPAMINE RECEPTOR INTERACTIONS [J].
BARONE, P ;
DAVIS, TA ;
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (01) :109-114
[6]  
Breese G R, 1986, Adv Exp Med Biol, V204, P197
[7]  
BREESE GR, 1985, J PHARMACOL EXP THER, V235, P287
[8]   SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J].
BREESE, GR ;
MUELLER, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) :109-114
[9]  
BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413
[10]  
BREESE GR, 1985, J PHARMACOL EXP THER, V234, P447